The present review, which is part of the issue “Mitochondria in Liver Pathobiology”, provides an overview of the role of mitochondrial dysfunction and NLRP3 activation in ASH and NASH. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.